Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dent

Showing results (41-50 of 395) with videos related to

Pageof 40
Sort By:
Applied Spectroscopy|February 10, 2015
Coupled turbidity and spectroscopy problems: a simple algorithm for the volumetric analysis of optically thin or dilute two-phase systemsPaul Dent, Bin Deng, Jerry Goodisman, et al.
Seminars in Cancer Biology|October 24, 2019
The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinibLaurence A Booth, Jane L Roberts, Paul Dent
Expert Review of Anticancer Therapy|June 29, 2011
The potential of virus-based gene therapies for treatment of metastatic kidney cancerPaul Dent, David T Curiel, Paul B Fisher
Cancer Biology & Therapy|July 20, 2018
The CHK1 inhibitor SRA737 synergizes with PARP1 inhibitors to kill carcinoma cellsLaurence Booth, Jane Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|March 19, 2003
Coadministration of UCN-01 with MEK1/2 inhibitors potently induces apoptosis in BCR/ABL+ leukemia cells sensitive and resistant to ST1571Chunrong Yu, Yun Dai, Paul Dent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cellsChunrong Yu, Geoffrey Krystal, Paul Dent, et al.
Molecular and Cellular Biology|June 21, 2005
Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activationYun Dai, Mohamed Rahmani, Paul Dent, et al.
Cancer Biology & Therapy|February 9, 2012
Enhancing CHK1 inhibitor lethality in glioblastomaYong Tang, Yun Dai, Steven Grant, et al.
Experimental Cell Research|April 20, 2004
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor BortezomibChunrong Yu, Mohamed Rahmani, Paul Dent, et al.
Blood|September 17, 2005
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanismGirija Dasmahapatra, Mohamed Rahmani, Paul Dent, et al.
Pageof 40

Showing results (41-50 of 395) with videos related to

Sort By:
Pageof 40
Applied Spectroscopy|February 10, 2015
Coupled turbidity and spectroscopy problems: a simple algorithm for the volumetric analysis of optically thin or dilute two-phase systemsPaul Dent, Bin Deng, Jerry Goodisman, et al.
Seminars in Cancer Biology|October 24, 2019
The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinibLaurence A Booth, Jane L Roberts, Paul Dent
Expert Review of Anticancer Therapy|June 29, 2011
The potential of virus-based gene therapies for treatment of metastatic kidney cancerPaul Dent, David T Curiel, Paul B Fisher
Cancer Biology & Therapy|July 20, 2018
The CHK1 inhibitor SRA737 synergizes with PARP1 inhibitors to kill carcinoma cellsLaurence Booth, Jane Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|March 19, 2003
Coadministration of UCN-01 with MEK1/2 inhibitors potently induces apoptosis in BCR/ABL+ leukemia cells sensitive and resistant to ST1571Chunrong Yu, Yun Dai, Paul Dent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cellsChunrong Yu, Geoffrey Krystal, Paul Dent, et al.
Molecular and Cellular Biology|June 21, 2005
Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activationYun Dai, Mohamed Rahmani, Paul Dent, et al.
Cancer Biology & Therapy|February 9, 2012
Enhancing CHK1 inhibitor lethality in glioblastomaYong Tang, Yun Dai, Steven Grant, et al.
Experimental Cell Research|April 20, 2004
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor BortezomibChunrong Yu, Mohamed Rahmani, Paul Dent, et al.
Blood|September 17, 2005
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanismGirija Dasmahapatra, Mohamed Rahmani, Paul Dent, et al.
Pageof 40